Shareholder Sues To Halt Vote On Merger Deal Until More Information Is Provided

(November 13, 2019, 1:35 PM EST) -- NEW YORK — A shareholder of an autologous cell and gene therapy company sued the company and its board of directors in New York federal court on Nov. 11, seeking to enjoin a shareholder vote on a planned merger agreement until the defendants provide their investors with information pertaining to the deal that was omitted from Securities and Exchange Commission documents (Allan Burnaska v. Fibrocell Science Inc., et al., No. 19-10450, S.D. N.Y.)....

Attached Documents

Related Sections